News and resources | Resources
Infographic 25 May 2016

Understanding psoriasis

By IFPMA
Downloads
Infographic
Share

Psoriasis was recognized for the first time as a serious non-communicable disease at the World Health Assembly in 2014. To help bring the public health impact of psoriasis into focus and to help raise awareness of the range of ways that psoriasis can affect peoples’ lives, IFPMA presents the recommendations from the WHO Global report into one infographic.

Psoriasis infographic front

Psoriasis infographic back

 

 

About IFPMA

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. The industry’s two million employees discover, develop, and deliver medicines and vaccines that advance global health.

Learn more

Media Contact

Abigail Jones

Related news and resources

Statement 20 Mar 2023

WHO Intergovernmental Negotiating Body (INB) intersessional briefing on the “Sustainable and equitably distributed production”

On 20 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 7: Access to technology: promoting sustainable and equitably distributed production sustainable and equitably distributed production and transfer of technology and know-how” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).

Read more
Statement 20 Mar 2023

WHO Intergovernmental Negotiating Body (INB) intersessional briefing on the “Transfer of technology and know-how”

On 20 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 7: Access to technology: promoting sustainable and equitably distributed production and transfer of technology and know-how” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).

Read more
Statement 17 Mar 2023

WHO Intergovernmental Negotiating Body (INB) intersessional briefing on “One Health and the Quadripartite”

On 17 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 18: One Health and the Quadripartite” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).

Read more
Top